ACS Omega (Sep 2023)

Synthesis and Anti-Breast Cancer Potency of Mono- and Bis-(pyrazolyl[1,2,4]triazolo[3,4‑b][1,3,4]thiadiazine) Derivatives as EGFR/CDK‑2 Target Inhibitors

  • Mostafa E. Salem,
  • Esraa M. Mahrous,
  • Eman A. Ragab,
  • Mohamed S. Nafie,
  • Kamal M. Dawood

DOI
https://doi.org/10.1021/acsomega.3c05309
Journal volume & issue
Vol. 8, no. 38
pp. 35359 – 35369

Abstract

Read online

No abstracts available.